Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma.

J Exp Clin Cancer Res · 2023 · PMC10538246 · PMID 37759291

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

However, an increasing trend of the release of EVs from T and B cells after administration of anti-PD1 was evident in EVs from NRES and in all subsets of EVs, with the exception of those isolated from melanoma cells in long RES and RES > PRO (Fig.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.